Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84151-84200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05500001
Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
NARecruiting
100 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2025
4 conditions3 sponsors4 locations
NCT05502653
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
N/ARecruiting
100 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2027
3 conditions2 sponsors1 location
NCT05318365
Bladder and Bowel Dysfunction in Children
NARecruiting
100 participants
Started: Sep 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor3 locations
NCT05454111
CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation
NANot yet recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition10 sponsors1 location
NCT06279039
Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery
NARecruiting
38 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT07150104
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
PHASE1/PHASE2Active, not recruiting
14 participants
Started: Aug 31, 2022 · Completed: Mar 11, 2027
1 condition1 sponsor10 locations
NCT05252988
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
PHASE2Active, not recruiting
177 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2030
3 conditions3 sponsors55 locations
NCT05529199
Impact of Preoperative Hypocaloric Hyperproteinic Lipid Restricting Diet on Bariatric Surgery
N/ARecruiting
776 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05251389
FMT to Convert Response to Immunotherapy
PHASE1/PHASE2Recruiting
24 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT05852457
Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip
N/ARecruiting
250 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2027
6 conditions1 sponsor2 locations
NCT05656118
Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)
N/AActive, not recruiting
260 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor10 locations
NCT05500118
Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
N/ARecruiting
120 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2027
3 conditions1 sponsor1 location
NCT05547672
Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Men
NAActive, not recruiting
6 participants
Started: Aug 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT05345197
Emicizumab in Patients With Acquired Hemophilia A
PHASE2Recruiting
51 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors16 locations
NCT05220982
Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology
NARecruiting
32 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05524441
Fatigue in Short-Haul Operations
N/ARecruiting
204 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT05460767
Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma
PHASE1Recruiting
260 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05493254
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
NARecruiting
672 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05486000
To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure
NARecruiting
120 participants
Started: Aug 31, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05851144
South Texas Early Prevention Studies SNAP-Ed (STEPS SNAP-Ed)
NAActive, not recruiting
1,104 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2026
1 condition4 sponsors1 location
NCT05450406
The Inland Norway Healthy Life Center Study
NANot yet recruiting
60 participants
Started: Aug 31, 2022 · Completed: Jul 31, 2026
6 conditions1 sponsor0 locations
NCT05354765
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
NARecruiting
300 participants
Started: Aug 31, 2022 · Completed: Sep 3, 2026
2 conditions1 sponsor2 locations
NCT05083754
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PHASE1Recruiting
50 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05524584
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
PHASE2Active, not recruiting
20 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT05476757
Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169.
EARLY_PHASE1Not yet recruiting
5 participants
Started: Aug 31, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05666518
A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
N/ARecruiting
1,400 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05508906
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
PHASE1Recruiting
190 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2028
5 conditions3 sponsors16 locations
NCT05281471
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
PHASE3Recruiting
186 participants
Started: Aug 31, 2022 · Completed: Oct 31, 2026
7 conditions2 sponsors30 locations
NCT05132504
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
PHASE2Recruiting
30 participants
Started: Aug 31, 2022 · Completed: May 21, 2027
1 condition3 sponsors3 locations
NCT05489627
Medial Collateral Ligament Reconstruction With Anteromedial Reinforcement for Medial and Anteromedial Rotatory Knee Instability
NARecruiting
17 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06712940
Supportive Hospital-Based Intervention for Firearm Trauma
NARecruiting
350 participants
Started: Aug 31, 2022 · Completed: Mar 30, 2028
2 conditions2 sponsors1 location
NCT05243043
Interactive Resuscitation Application for Mothers About to Experience Premature Infant Resuscitation
N/ARecruiting
80 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04449146
Scapular Positioning in Standing Position Using Sonography
NARecruiting
30 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT04972760
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
PHASE3Recruiting
62 participants
Started: Aug 31, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05155046
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
PHASE2Recruiting
130 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05502523
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NARecruiting
100 participants
Started: Aug 31, 2022 · Completed: Jan 1, 2029
4 conditions1 sponsor4 locations
NCT05273554
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
PHASE1Active, not recruiting
14 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05426434
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
PHASE3Active, not recruiting
1,172 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
3 conditions5 sponsors1 location
NCT05357443
SH Dr. Chen Gastric Bypass Study
NAActive, not recruiting
50 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05518500
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
PHASE4Recruiting
75 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
4 conditions6 sponsors1 location
NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancer
PHASE1/PHASE2Recruiting
68 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
8 conditions1 sponsor84 locations
NCT05889546
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
N/ARecruiting
30 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor3 locations
NCT05387837
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
PHASE2Active, not recruiting
50 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor16 locations
NCT05459844
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
PHASE3Active, not recruiting
196 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor23 locations
NCT05445063
Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
PHASE1Recruiting
10 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05475184
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
PHASE2Active, not recruiting
58 participants
Started: Aug 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04794582
Prevention of Incisional Hernia After Renal Transplantation
NARecruiting
160 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05303727
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
PHASE2Not yet recruiting
64 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05373251
PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer
NANot yet recruiting
500 participants
Started: Aug 31, 2022 · Completed: Aug 31, 2032
1 condition1 sponsor0 locations
NCT05521490
Combating Physical Inactivity Pandemic in Kindergartens
NARecruiting
3,300 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
2 conditions8 sponsors1 location